Mayo researchers: Dramatic outcomes in prostate cancer study
Friday, June 19, 2009 - 14:07
in Health & Medicine
Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardized hormone treatment and radiation therapy. The men were participating in a clinical trial of an immunotherapeutic agent called MDX-010 or ipilimumab. In these two cases, physicians say the approach initiated the death of a majority of cancer cells and caused the tumors to shrink dramatically, allowing surgery. In both cases, the aggressive tumors had grown well beyond the prostate into the abdominal areas.
Read the whole article on Physorg
More from Physorg
Related
- Mayo researchers: Dramatic outcomes in prostate cancer studyFri, 19 Jun 2009, 15:11:50 EDT
- OHSU Cancer Institute finds that drug stimulated immune system in prostate cancerMon, 2 Jun 2008, 14:14:53 EDT
- New tool helps physicians tailor hormone therapy for high-risk prostate cancer patientsTue, 23 Sep 2008, 14:09:26 EDT
- Selected men with low-risk prostate cancer have good clinical outcomes without immediate treatmentMon, 16 Mar 2009, 0:29:16 EDT
- Why prostate cancer patients fail hormone deprivation therapyWed, 31 Dec 2008, 10:08:16 EST